Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:18 PM
Ignite Modification Date:
2025-12-24 @ 12:18 PM
NCT ID:
NCT06624761
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 18 and over who speak Turkish,
* Who have signed the informed consent form,
* Who are admitted to the emergency room for prescription drug use or who are planned to use diclofenac sodium and metamizole sodium as IMI upon the directive of the emergency room physician will constitute.
Exclusion Criteria:
* Pregnant women,
* Those with psychiatric disorders,
* Those with hearing or vision problems,
* Those who applied to the red area of the emergency room,
* Those with impaired consciousness,
* Those with secondary injuries and infections at the injection site,
* Those who have previously received an injection at the same site within the last 24 hours, -Those who did not sign the informed consent form for the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06624761
Study Brief:
Protocol Section:
NCT06624761